Extraordinary General Meeting of Shareholders
Pursuant to Article 365 of the Korean Commercial Act and Article 21 of the Articles of Incorporation, SCAI Therapeutics Co., Ltd. hereby announces that an Extraordinary General Meeting of Shareholders will be held as follows. Your attendance is kindly requested.
Details of the Meeting
Date and Time:
Wednesday, May 21, 2025, at 10:00 a.m.
Venue:
12th Floor, D&0 Gangnam Building, 2621 Nambusunhwan-ro, Gangnam-gu, Seoul, Republic of Korea
Agenda: Proposals for Resolution:
-
Approval of Amendments to the Articles of Incorporation (see Attachment 1)
-
Approval of the Regulations on Executive Retirement Benefits
-
Election of Outside Director: Hyun-Kook Kim
Exercise of Voting Rights:
Shareholders may exercise their voting rights either in person at the meeting or by proxy in accordance with the power of attorney.
April 30, 2025
SCAI Therapeutics Co., Ltd.
Chief Executive Officer: Chul hwan Kim